According to Acorda Therapeutics 's latest financial reports the company's current EPS (TTM) is -8,60ย โฌ. In 2022 the company made an earnings per share (EPS) of -77,57ย โฌ an increase over its 2021 EPS that were of -175,55ย โฌ.